Genpharmasec Limited - Due diligence report

A 360° intelligence report on Genpharmasec Limited: trust score, financial health, credit view, compliance, directors, growth and distress s…

1992-11-16 Mumbai, Maharashtra Active Listed Active Compliant
Share
GL Genpharmasec Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Genpharmasec Limited — 360° Intelligence Report

Generated from MCA filings & public records
68/100
Trust Score
Moderate

Genpharmasec Limited is assessed as Moderate with a Trust Score of 68/100. Genpharmasec Limited is an active public limited indian non-government company incorporated in 1992, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Genpharmasec Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Weak

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
68/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
38/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 2 open (12.50 cr) · 7 satisfied (30.35 cr).

Banking relationships (from registered charges)
LenderChargesAmount
International Asset Reconstruction Company Pvt. Ltd.4 48.0 cr
Hdfc Bank Limited3 48.0 cr
Others2 48.0 cr
Compliance Score: 38/100 Caution Indicated
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: BSE, MCA.
  • Litigation present in 2 court forum(s).
  • 1 auditor resignation(s) filed - latest: MOHANDAS & CO. on 2015-08-17.
  • Delayed payments to MSME suppliers disclosed (2 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
MAYUR BHARATBHAI BHATT 01234567 Director 01/04/2018 6 yrs Approved
SACHIN PRAKASH APHANDKAR 01234567 Director 01/04/2018 6 yrs Approved
SOHAN CHATURVEDI 01234567 Director 01/04/2018 6 yrs Approved
SIDDHESH SHANKAR SHENDE 01234567 Director 01/04/2018 6 yrs Approved
SOHAN CHATURVEDI 01234567 Director 01/04/2018 6 yrs Approved
RAJESH MIRCHUMAL SADHWANI 01234567 Director 01/04/2018 6 yrs Approved
SNEHA SADHWANI 01234567 Director 01/04/2018 6 yrs Approved
Hardik Pravinbhai Makwana 01234567 Director 01/04/2018 6 yrs Approved
  • 8 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2025)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2025 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Key managerial personnel: SOHAN CHATURVEDI (CFO) · SOHAN CHATURVEDI (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 65
Growth signals & trust indicators
Operating for 33+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Profit declined two years in a row.
Compliance score is weak (38/100).
2 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 38,940.00.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence55/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 12.50 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view61/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
20 Dec 2025
Charge created
Hdfc Bank Limited - 10.00 cr
17 Dec 2025
Charge satisfied
Others
04 Dec 2025
Charge satisfied
Hdfc Bank Limited
29 Sep 2025
Last AGM held
Annual general meeting
03 Jul 2025
Charge created
Hdfc Bank Limited - 1.50 cr
23 May 2025
Charge created
Hdfc Bank Limited - 2.50 cr
06 May 2025
Charge created
Others - 2.50 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
26 Apr 2024
Director appointed
SOHAN CHATURVEDI (Whole-time director)
08 Apr 2024
Director appointed
Hardik Pravinbhai Makwana (Company Secretary)
20 Mar 2024
Director ceased
Heta Viraj Shah
24 May 2023
Charge created
Others - 3.00 cr
27 Feb 2023
Director ceased
MAYUR BHARATBHAI BHATT
01 Nov 2022
Director appointed
MAYUR BHARATBHAI BHATT (Director)
Director appointed
SACHIN PRAKASH APHANDKAR (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - manageable leverage.
Net worth is positive.
8 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a majority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Ghushine Fintrrade Ocean Limited L65910GJ1995PLC025823 Surat, Gujarat, India
Magna Industries And Exports Limited L24246MH1989PLC052389 Mumbai, Maharashtra, India
Uni-Pex Pharmaceuticals Private Limited U24231DL1999PTC098759 Delhi, Delhi, India
Shoora Designs Limited L74110GJ2021PLC120894 Surat, Gujarat, India
R.T. Exports L68100MH1980PLC022582 Mumbai, Maharashtra, India
Shukra Jewellery Limited L52393GJ1991PLC079516 Ahmedabad, Gujarat, India
Lumicon Solutions Private Limited U51909UP2018PTC109589 Agra, Uttar Pradesh, India
Sctl L51909GJ1997PLC031561 Ahmadabad City, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Genpharmasec Limited before audits and certifications: compliance score 38/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Genpharmasec Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 40/100, margin trends, ownership structure and peer set for Genpharmasec Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Genpharmasec Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Genpharmasec Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Genpharmasec Limited an active company?

Genpharmasec Limited has MCA status “Active” with a compliance score of 38/100 (Caution Indicated).

Is Genpharmasec Limited financially healthy?

Genpharmasec Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Genpharmasec Limited?

Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Genpharmasec Limited?

Promoters hold a majority stake - exact percentages are in the full report. 8 active director(s) are on record.

Does Genpharmasec Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 7 earlier charge(s) stand satisfied.

Is Genpharmasec Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 38/100 (Caution Indicated).

Is it risky to lend to Genpharmasec Limited?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.